New Delhi: After a thorough review exercise spanning over two days the Department of Pharmaceuticals (DoP) released the Global Tender Enquiry (GTE) exemption list.

The committee chaired by the Secretary of Department of Pharmaceuticals and consisting of representatives from DoP, CDSCO, DGHS and AIIMS reviewed the claims of all cohorts. The nodal department had invited both global and domestic manufacturers to provide supporting documents and justifications to review and finalize the GTE exemption list.

More than 100 representatives from both global and domestic MediTech companies participated in the meeting and presented the substantiations of their claims.

Speaking over the development, Pavan Choudary, Chairman, Medical Technology Association of India (MTaI) said, “This is a path breaking effort by the government towards equitable policy making, spanning the crucial last mile which was uncovered so far. This exercise has leveled the playing field and its ultimate beneficiary will be the patient who will have continued access to quality products till reliable import substitutes are available, and the nation because such a system of checks and balances will not allow sub-par product launches to tar our reputation as a reliable manufacturing destination. “This reputation will assist our growing exports and the foreign investor on seeing that the government staff is taking such pains to ensure policy making is fair will also be encouraged” Choudary added.

  • Published On Jul 1, 2024 at 09:04 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles

Scan to download App